Use of Vibration Anesthesia Device in Intratympanic Injections

Launched by YUZUNCU YIL UNIVERSITY · Mar 19, 2025

Keywords

ClinConnect Summary

ABSTRACT In this study, we aimed to compare the efficacy of four methods including topical lidocaine spray, local anesthetic cream, vibration anesthesia device (VAD), and saline drops (control group) in the reduction of pain after intratympanic steroid injections (ITS's) and to demonstrate the effectiveness of VAD use. The prospective study included 40 patients aged 18-70 years with idiopathic sudden sensorineural hearing loss. Prior to each ITS, all the four methods including local anesthetic cream (EMLA® cream, AstraZeneca PLC), lidocaine spray (Vemcain® Spray), VAD (Blaine®, Blaine Labs,...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 18-70 years with idiopathic sudden sensorineural hearing loss
• Exclusion Criteria:
• • History of otologic surgery,
• • Recent ototoxic drug use,
• • Congenital inner ear malformation,
• • History of chemoradiotherapy due to malignant neoplasia,
• • Presence of acute or chronic otitis media,
• • Age under 18 years, over 70 years
• • History of local anesthesia allergy,
• • Coagulation abnormality,
• • Pregnant and lactating women,
• • Hearing cases with other neurootological diseases